October 27, 2021

More than a Gut Check: Behind-the-Scenes with Startup Leaders Breaking New Ground in the Microbiome Industry

Microbiome is a big biotech buzz word these days and the industry is poised for explosive growth amidst increasing interest in and understanding of the relationships between the human microbiome, disease and immunity. Private capital and government funding are aligning, with a surge in investment helping to fuel rapid acceleration in both research and commercialization.

Listen in for a special “Inside the Microbiome Industry” edition of Genome Startup Day with researcher Chris Mason, PhD, professor at Weill Cornell Medicine, and Ivan Liachko, PhD, founder of Genome Startup Day and CEO of Phase Genomics leading with a fireside chat. Following their discussion, Colleen Cutcliffe, PhD (Pendulum Therapeutics), Nick Greenfield (Invitae) and Momchilo “Momo” Vuyisich, PhD (Viome) take the floor with candid and insightful exploration of the lifecycle of launching and growing a genomics startup including the ins and outs of building a company today in the human microbiome space moderated by the “This Week in Science” podcast host, Dr. Kirsten Sanford.


Thank you to our speakers

Photo of man in black and white


Founder & CEO at Phase Genomics

Image of man in a lab


Professor at Weill Cornell Medicine and Co-Founder of five genomics companies, including Onegevity Health and Biotia, Inc.

Image of woman in a lab


Cofounder & CEO of Pendulum Therapeutics

Black and white image of a man


Head of Microbiome at Invitae

Image of man in a suit


Co-founder and Chief Science Officer at Viome, Inc

woman in orange shirt


Vice President of Public Relations at Science Talk, Owner of Broader Impacts Productions, Host of This Week in Science

Join the community and stay informed